A systematic review on the effects of high frequency chest wall compression and intrapulmonary percussive ventilation in patients with neuromuscular disease
Background: Patients with neuromuscular disease develop progressively inspiratory and expiratory muscle weakness and can also present impaired glottic function. Airway obstruction is the result of secretion retention and it is known that respiratory insufficiency is the most common cause of death in...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Dataset |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Patients with neuromuscular disease develop progressively
inspiratory and expiratory muscle weakness and can also present impaired
glottic function. Airway obstruction is the result of secretion retention
and it is known that respiratory insufficiency is the most common cause of
death in this population. Therefore, it is important to main clear
airways. At some point, the active participation of the patient is not
possible due to muscle weakness and other options must be explored.
High-frequency chest wall compression and intrapulmonary percussive
ventilation are two interventions that do not require the active
participation of patients. Objective: We performed a systematic review on
the effects of high-frequency chest wall compression and intrapulmonary
percussive ventilation in patients with neuromuscular disease Method: Our
systematic review followed the recommendation of the PRISMA statement. We
performed our research strategy on PubMed, CINHAL, Pedro, Cochrane, and
EMBASE. The word combination was initially performed on PubMed and then
adapted to the other databases. In our systematic review, we also assessed
the risk of bias in the included studies. We used the risk of bias tool
version 2.0 tools (9 October 2018 version). Result: The PRISMA checklist
was complete to enable control that all points of the checklist are
reported in the paper and in which section and page the information can be
found (see document Prisma checklist). We found 161 records on PubMed, 229
on EMBASE, 118 on Cochrane, 312 on Pedro, and 760 CINAHL. More information
can be found in the document called “Extended data File 1” of the research
strategy of all databases. Regarding the risk of bias, we concluded that
all included studies had a high risk of bias (see more detail for each
point the extended data file 2). Conclusion: We make available our
research strategy to enable other researchers to reproduce the research
strategy to update the systematic review. Moreover, we make available our
analysis of the risk of bias to be transparent. |
---|---|
DOI: | 10.5061/dryad.n8pk0p2tj |